Donovan Quill, President and CEO, Optime Care, interview featured on April 21, 2021: Addressing Unique Needs of Specialty Drug Patients, Enhancing Care Quality, and Improving Outcomes
For stakeholders looking to optimize the quality of care, impact the patient experience and improve outcomes for the 30 million Americans living with a range of 7,000 rare or orphan diseases requires a patient-first approach.
During the remaining months of the COVID-19 pandemic and beyond, pharmaceutical companies, pharmacists, physicians and other members of the care team can better address compliance and adherence to treatment when the patient is at the center of all care coordination.
This article highlights Optime Care’s patient-first business model and how it allows physicians, specialty pharmacy, patients and care coordinators to connect effortlessly, rather than operating independently. Optime Care’s higher level of care continuity strengthens communication, yields rich data for more informed decision making and improves the overall patient experience.
